Cargando…

Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus

INTRODUCTION: Accelerated atherosclerosis is one of the major causes of morbidity in patients with systemic lupus erythematosus (SLE). Endothelial dysfunction (ED) is considered an early marker of atherosclerosis. It is a reversible alteration, thus representing an attractive target for prevention s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virdis, Agostino, Tani, Chiara, Duranti, Emiliano, Vagnani, Sabrina, Carli, Linda, Kühl, Anja A., Solini, Anna, Baldini, Chiara, Talarico, Rosaria, Bombardieri, Stefano, Taddei, Stefano, Mosca, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594997/ https://www.ncbi.nlm.nih.gov/pubmed/26444671 http://dx.doi.org/10.1186/s13075-015-0790-3

Ejemplares similares

Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus
por: Tani, Chiara, et al.
Publicado: (2017)

Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II
por: Virdis, Agostino, et al.
Publicado: (2011)

Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus
por: Carli, L, et al.
Publicado: (2016)

Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream
por: Zucchi, Dina, et al.
Publicado: (2023)

Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort
por: Tani, Chiara, et al.
Publicado: (2018)

Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus
por: Elefante, Elena, et al.
Publicado: (2020)

Vascular Dysfunction in a Mouse Model of Rett Syndrome and Effects of Curcumin Treatment
por: Panighini, Anna, et al.
Publicado: (2013)

The renal resistive index is associated with microvascular remodeling in patients with severe obesity
por: Moriconi, Diego, et al.
Publicado: (2023)

Adipocytokine levels mark endothelial function in normotensive individuals
por: Solini, Anna, et al.
Publicado: (2012)

Systemic lupus erythematosus: state of the art on clinical practice guidelines
por: Tamirou, Farah, et al.
Publicado: (2019)

Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience
por: Tani, Chiara, et al.
Publicado: (2019)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life
por: Elefante, Elena, et al.
Publicado: (2022)

Donepezil improves vascular function in a mouse model of Alzheimer’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021)

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus
por: Elefante, Elena, et al.
Publicado: (2020)

The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
por: Kernder, Anna, et al.
Publicado: (2020)

Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare
por: Zucchi, Dina, et al.
Publicado: (2021)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
por: Piñero, David P., et al.
Publicado: (2017)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
por: Aouhab, Z., et al.
Publicado: (2019)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
por: Cornet, Alain, et al.
Publicado: (2021)

Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
por: Talarico, Rosaria, et al.
Publicado: (2020)

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment
por: Olsen, Nancy J., et al.
Publicado: (2016)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine
por: Baalbaki, Sima, et al.
Publicado: (2020)

Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus
por: Hammami, Sonia, et al.
Publicado: (2014)

Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE – 18 months later
por: Cornet, Alain, et al.
Publicado: (2023)

Extensive Discoid Lupus Erythematosus in a HIV patient Responding to Hydroxychloroquine Monotherapy
por: Bhagwat, Pradeep Vittal, et al.
Publicado: (2012)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
por: Bajwa, Asima, et al.
Publicado: (2015)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
por: Wang, Wen-Ming, et al.
Publicado: (2018)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
por: Zahr, Noël, et al.
Publicado: (2021)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
por: Abdelbaky, Mohammed Salah Eldin, et al.
Publicado: (2021)

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine
por: Reynolds, John A, et al.
Publicado: (2022)

Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus
por: Hevia, Arancha, et al.
Publicado: (2014)

Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren’s syndrome
por: Baldini, Chiara, et al.
Publicado: (2015)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
por: O'Laughlin, John P., et al.
Publicado: (2016)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
por: Fernandez-Ruiz, Ruth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_krdklt5ia3d35j70u44kduo8di